Isoflurane induces c-Fos expression in the area postrema of the rat

J Anesth. 2019 Aug;33(4):562-566. doi: 10.1007/s00540-019-02662-0. Epub 2019 Jul 17.

Abstract

Introduction: Volatile anesthetics are speculated to cause postoperative nausea and vomiting via stimulation of the chemoreceptor trigger zone (CTZ). However, the precise mechanism underlying the emetic action of these drugs is not well understood. In this study, we assessed whether isoflurane induced the expression of c-Fos, a neuronal activation marker, in the area postrema (AP), the locus of the CTZ, in rats, which do not have vomiting action.

Materials and methods: Male rats were exposed to 1.3% isoflurane for 0-240 min, or to various concentrations of isoflurane (0, 1.3%, or 2.6%) for 120 min. Finally, the rats were exposed to 1.3% isoflurane for 120 min after ondansetron administration. After the treatments, immunohistochemistry of the rat AP was performed using c-Fos antibody staining.

Results: One-way analysis of variance showed that isoflurane exposure significantly increased c-Fos expression in the AP; however, the rats pretreated with 4 mg/kg ondansetron showed significantly decreased c-Fos expression. Moreover, we evaluated the effect of the anesthetic on inducing pica in the rats, and found that kaolin intake was not influenced by isoflurane exposure.

Conclusion: Overall, these results suggest that isoflurane activates AP neurons and may be involved in the emetic mechanism of isoflurane. This study further suggests the feasibility of using rats as a model for studying emetic mechanisms of drugs, despite their lack of vomit action.

Keywords: Area postrema; Isoflurane; Ondansetron; c-Fos.

MeSH terms

  • Anesthetics, Inhalation / pharmacology*
  • Animals
  • Area Postrema / drug effects*
  • Isoflurane / pharmacology*
  • Male
  • Neurons / metabolism
  • Ondansetron / pharmacology
  • Proto-Oncogene Proteins c-fos / metabolism*
  • Rats
  • Rats, Wistar
  • Vomiting / chemically induced

Substances

  • Anesthetics, Inhalation
  • Proto-Oncogene Proteins c-fos
  • Ondansetron
  • Isoflurane